Related Experiment Video
Updated: Jan 25, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
Published on: August 17, 2022
Short-Term Semaglutide Improves Safety in High Body Weight Recipients Undergoing Living Donor Liver Transplant: A
Ssu-Min Cheng1, Yin Lai, Ruo-Yi Huang
1From the Nursing Department, Chang Gung Memorial Hospital at Linkou, Taoyuan; and the School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Abstract:
Living donor liver transplant has recently become increasingly important as a solution to the shortage of deceased donor livers. The success of adult-to-adult living donor liver transplant depends on achievement of an appropriate graft-to-recipient weight ratio to prevent complications like small-for-size syndrome. This case report describes the use of oral semaglutide, a glucagon-like peptide-1 receptor agonist, to faci-litate pretransplant weight loss in an obese patient (body mass index 39.1, in kg/m2) undergoing living donor liver transplant. The patient experienced a significant weight loss of 10 kg during a period of 19 days with semaglutide treatment, which improved the graft-to-recipient weight ratio (from 0.66% to 0.786%) and resulted in an uneventful living donor liver transplant procedure with no postoperative issues. This case marks the first documented case of using semaglutide for pretransplant weight loss in liver transplant recipients, highlighting its potential to improve surgical outcomes for overweight patients awaiting transplant.
Related Concept Videos
Survey Safety
Weighted Mean
For example, consider the number of goals scored in the matches of a tournament. While computing the average number of goals scored in the tournament, it may be more important to...
Mass and Weight
Atomic Weight
Long-term Depression
Apparent Weight
Consider a person standing on a bathroom scale inside an elevator. If the scale is accurate at rest, its reading equals the...

